To explore the pathogenesis of gastric cancer from epigenome, transcriptome and proteomics

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200056730

Enrollment

Unknown

Registered

2022-02-12

Start date

2021-10-01

Completion date

Unknown

Last updated

2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Those who were diagnosed with gastric cancer by gastroscope and pathological examination; 2. Those aged 18-80 years; 3. Those who signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors in other parts; 2. Cognitive impairment or mental illness; 3. Complicated with severe dysfunction of heart, lung, brain, kidney, blood, and other systems or organ injury; 4. Participating in other clinical trials, which may have an impact on the results of this study; 5. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Gastric cancer gene;Cis-regulatory element;Trans-acting factor;	—

Countries

China

Contacts

Public ContactKai Deng

West China Hospital, Sichuan University

dengkai@wchscu.cn+86 18224451156

Outcome results